Peptide-based treatment of sepsis

Applied Microbiology and Biotechnology

Volumn 90, Issue 3, 2011, Pages 799-808

  Brandenburg, Klaus ^a   Andrä, Jörg ^a   Garidel, Patrick ^b,c   Gutsmann, Thomas ^a  

^a RESEARCH CENTER BORSTEL   (Germany)

^b MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

^c Rheinland Pfälzische Technische Universität Kaiserslautern Landau   (Germany)

Author keywords

Antimicrobial peptides; Defensins; Endotoxin; Limulus; Lipopolysaccharide; Sepsis

Indexed keywords

ANTIMICROBIAL PEPTIDE; DEFENSINS; ENDOTOXIN; LIMULUS; LIPOPOLYSACCHARIDES; SEPSIS;

ANIMALS; BACTERIA; DISEASE CONTROL; PATHOLOGY;

PEPTIDES;

CATHELICIDIN; CLALF10; CLALF18; CLALF20; CLALF22; DEFB123; DEFENSIN; GRANULYSIN; HCAP18; LACTOFERRIN; LAURYL LF11; NK 2; NK LYSINE; PMB1; PMB2; PMB3; PMB4; POLYPEPTIDE ANTIBIOTIC AGENT; RCAP18; SPHINGOLIPID ACTIVATOR PROTEIN; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANTIMICROBIAL ACTIVITY; BACTERIUM; DRUG; INFECTIOUS DISEASE; MORTALITY; PEPTIDE; TOXIN;

ANTIBACTERIAL ACTIVITY; BIOLOGICAL ACTIVITY; CYTOKINE PRODUCTION; CYTOTOXICITY; DRUG EFFECT; HUMAN; LIMULUS LYSATE TEST; MONONUCLEAR CELL; NONHUMAN; REVIEW; SEPSIS;

ANIMALS; ANTI-BACTERIAL AGENTS; ENDOTOXINS; GRAM-NEGATIVE BACTERIA; GRAM-NEGATIVE BACTERIAL INFECTIONS; HUMANS; PEPTIDES; SEPSIS;

ANIMALIA; LIMULUS; NEGIBACTERIA;

EID: 79954637465     PISSN: 01757598     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00253-011-3185-7     Document Type: Review

References (69)

1. B Agerberth J Grunewald E Castanos-Velez B Olsson H Jornvall H Wigzell A Eklund GH Gudmundsson 1999 Antibacterial components in bronchoalveolar lavage fluid from healthy individuals and sarcoidosis patients Am J Respir Crit Care Med 160 283 290 1:STN:280:DyaK1Mzit1artg%3D%3D (Pubitemid 29326101)
2. M Andersson H Gunne B Agerberth A Boman T Bergman R Sillard H Jornvall V Mutt B Olsson H Wigzell 1995 NK-lysin, a novel effector peptide of cytotoxic T and NK cells. Structure and cDNA cloning of the porcine form, induction by interleukin 2, antibacterial and antitumour activity EMBO J 14 1615 1625 1:CAS:528:DyaK2MXlsl2gsb4%3D
3. M Andersson H Gunne B Agerberth A Boman T Bergman B Olsson A Dagerlind H Wigzell HG Boman GH Gudmundsson 1996 NK-lysin, structure and function of a novel effector molecule of porcine T and NK cells Vet Immunol Immunopathol 54 123 126 10.1016/S0165-2427(96)05677-2 1:CAS:528:DyaK2sXnt1OjtA%3D%3D (Pubitemid 27035578)
4. M Andersson R Girard P Cazenave 1999 Interaction of NK lysin, a peptide produced by cytolytic lymphocytes, with endotoxin Infect Immun 67 201 205 1:CAS:528:DyaK1MXisFSgsQ%3D%3D (Pubitemid 29021649)
5. J Andrä P Garidel A Majerle R Jerala R Ridge E Paus T Novitsky MHJ Koch K Brandenburg 2004 Biophysical characterization of the interaction of Limulus polyphemus endotoxin neutralizing protein with lipopolysaccharide Eur J Biochem 271 2037 2046 10.1111/j.1432-1033.2004.04134.x (Pubitemid 38657356)
6. J Andrä MHJ Koch R Bartels K Brandenburg 2004 Biophysical characterization of endotoxin inactivation by NK-2, an antimicrobial peptide derived from mammalian NK-lysin Antimicrob Agents Chemother 48 1593 1599 10.1128/AAC.48.5.1593-1599.2004 (Pubitemid 38544364)
7. J Andrä M Lamata G Martinez de Tejada R Bartels MHJ Koch K Brandenburg 2004 Cyclic antimicrobial peptides based on Limulus anti-lipopolysaccharide factor for neutralization of lipopolysaccharide Biochem Pharmacol 68 1297 1307 10.1016/j.bcp.2004.05.054 (Pubitemid 39185859)
8. J Andrä K Lohner SE Blondelle R Jerala I Moriyon MHJ Koch P Garidel K Brandenburg 2005 Enhancement of endotoxin neutralization by coupling of a C12-alkyl chain to a lactoferricin-derived peptide Biochem J 385 135 143 10.1042/BJ20041270
9. J Andrä T Gutsmann P Garidel K Brandenburg 2006 Mechanisms of endotoxin neutralization by synthetic cationic compounds J Endotoxin Res 12 261 277 (Pubitemid 47471338)
10. J Andrä J Howe P Garidel M Rössle W Richter J Leiva-Leon I Moriyon R Bartels T Gutsmann K Brandenburg 2007 Mechanism of interaction of optimized Limulus-derived cyclic peptides with endotoxins: thermodynamic, biophysical and microbiological analysis Biochem J 406 297 307 10.1042/BJ20070279 (Pubitemid 47310960)
11. J Andrä D Monreal G Martinez de Tejada C Olak G Brezesinski SS Gomez T Goldmann R Bartels K Brandenburg I Moriyon 2007 Rationale for the design of shortened derivatives of the NK-lysin-derived antimicrobial peptide NK-2 with improved activity against Gram-negative pathogens J Biol Chem 282 14719 14728 10.1074/jbc.M608920200 (Pubitemid 47093359)
12. BJ Appelmelk Y-Q An M Geerts BG Thijs HA De Boer DM MacLaren J De Graaff JH Nuijens 1994 Lactoferrin is a lipid A-binding protein Infect Immun 62 2628 2632 1:CAS:528:DyaK2MXhsFemtg%3D%3D (Pubitemid 24157102)
13. JD Baumgartner D Heumann J Gerain P Weinbreck GE Grau MP Glauser 1990 Association between protective efficacy of anti-lipopolysaccharide (LPS) antibodies and suppression of LPS-induced tumor necrosis factor alfa and interleukin 6 J Exp Med 171 889 896 10.1084/jem.171.3.889 1:CAS:528: DyaK3cXhsFKgt70%3D (Pubitemid 20088989)
14. DM Bowdish RE Hancock 2005 Anti-endotoxin properties of cationic host defence peptides and proteins J Endotoxin Res 11 230 236 (Pubitemid 41358858)
15. K Brandenburg G Jürgens M Müller S Fukuoka MHJ Koch 2001 Biophysical characterization of lipopolysaccharide and lipid A inactivation by lactoferrin Biol Chem 382 1215 1225 10.1515/BC.2001.152 1:CAS:528: DC%2BD3MXnslGlt7Y%3D (Pubitemid 32894028)
16. K Brandenburg A David J Howe MHJ Koch J Andrä P Garidel 2005 Temperature dependence of the binding of endotoxins to the polycationic peptides polymyxin B and its nonapeptide Biophys J 88 1845 1858 10.1529/biophysj.104. 047944 1:CAS:528:DC%2BD2MXis1WhtbY%3D (Pubitemid 40976198)
17. K Brandenburg P Garidel S Fukuoka J Howe MHJ Koch T Gutsmann J Andrä 2010 Molecular basis for endotoxin neutralization by amphipathic peptides derived from the alpha-helical cationic core-region of NK-lysin Biophys Chem 150 80 87 10.1016/j.bpc.2010.01.009 1:CAS:528:DC%2BC3cXntlantrc%3D
18. X Chen J Howe J Andrä M Rössle W Richter AP da Silva AM Krensky C Clayberger K Brandenburg 2007 Biophysical analysis of the interaction of granulysin-derived peptides with enterobacterial endotoxins Biochim Biophys Acta 1768 2421 2431 10.1016/j.bbamem.2007.05.001 1:CAS:528:DC%2BD2sXhtFGrsr3P (Pubitemid 47542311)
19. CD Ciornei T Sigurdardottir A Schmidtchen M Bodelsson 2005 Antimicrobial and chemoattractant activity, lipopolysaccharide neutralization, cytotoxicity, and inhibition by serum of analogs of human cathelicidin LL-37 Antimicrob Agents Chemother 49 2845 2850 10.1128/AAC.49.7.2845-2850.2005 1:CAS:528: DC%2BD2MXlvFSls70%3D (Pubitemid 40917601)
20. JB Cowland AH Johnsen N Borregaard 1995 hCAP-18, a cathelin/pro- bactenecin-like protein of human neutrophil specific granules FEBS Lett 368 173 176 10.1016/0014-5793(95)00634-L 1:CAS:528:DyaK2MXmvVemtrw%3D
21. AS Cross SM Opal 1995 Endotoxin's role in Gram-negative bacterial infection Curr Opin Infect Dis 8 156 163 10.1097/00001432-199506000-00003
22. DN Cruz R Bellomo C Ronco 2007 Clinical effects of polymyxin B-immobilized fiber column in septic patients Contrib Nephrol 156 444 451 10.1159/000102138
23. S Dankesreiter A Hoess J Schneider-Mergener H Wagner T Mietke 2000 Synthetic endotoxin-binding peptides block endotoxin-triggered TNF-α production by macrophages in vitro and in vivo and prevent endotoxin-mediated toxic shock J Immunol 164 4804 4811 1:CAS:528:DC%2BD3cXivFWmurk%3D (Pubitemid 30238083)
24. EG Davis Y Sang B Rush G Zhang F Blecha 2005 Molecular cloning and characterization of equine NK-lysin Vet Immunol Immunopathol 105 163 169 10.1016/j.vetimm.2004.12.007 1:CAS:528:DC%2BD2MXis1KhsL4%3D (Pubitemid 41569217)
25. CJ de Haas PJ Haas KP van Kessel JA van Strijp 1998 Affinities of different proteins and peptides for lipopolysaccharide as determined by biosensor technology Biochem Biophys Res Commun 252 492 496 10.1006/bbrc.1998. 9675 (Pubitemid 28542915)
26. A Deng S Chen Q Li SC Lyu C Clayberger AM Krensky 2005 Granulysin, a cytolytic molecule, is also a chemoattractant and proinflammatory activator J Immunol 174 5243 5248 1:CAS:528:DC%2BD2MXjsVertrY%3D (Pubitemid 40593162)
27. JF Dhainaut SB Yan DE Joyce V Pettila B Basson T Brandt DP Sundin ML Levis 2004 Treatment effects of drotrecogin alfa (activated) in patients with severe sepsis with or without overt disseminated intravascular coagulation J Thromb Haemost 2 1924 1833 10.1111/j.1538-7836.2004.00955.x 1:CAS:528: DC%2BD2cXhtFagsLzK (Pubitemid 40192745)
28. E Elass-Rochard D Legrand V Salmon A Roseanu M Trif PS Tobias J Mazurier G Spik 1998 Lactoferrin inhibits the endotoxin interaction with CD14 by competition with the lipopolysaccharide-binding protein Infect Immun 66 486 491 1:CAS:528:DyaK1cXmslOmtA%3D%3D (Pubitemid 28074186)
29. JJ Endsley JL Furrer MA Endsley MA McIntosh AC Maue WR Waters DR Lee DM Estes 2004 Characterization of bovine homologues of granulysin and NK-lysin J Immunol 173 2607 2614 1:CAS:528:DC%2BD2cXmt1Olurs%3D (Pubitemid 39063120)
30. ME Falagas SK Kasiakou 2006 Toxicity of polymyxins: a systematic review of the evidence from old and recent studies Crit Care 10 R27 10.1186/cc3995 (Pubitemid 47079794)
31. M Frohm H Gunne AC Bergman B Agerberth T Bergman A Boman S Liden H Jornvall HG Boman 1996 Biochemical and antibacterial analysis of human wound and blister fluid Eur J Biochem 237 86 92 10.1111/j.1432-1033.1996.0086n.x 1:CAS:528:DyaK28Xitlyjur4%3D (Pubitemid 26110276)
32. P Garidel K Brandenburg 2009 Current understanding of polymyxin B applications in bacteraemia/sepsis therapy prevention: clinical, pharmaceutical, structural and mechanistic aspects Antiinfect Agents Medic Chem 8 367 385 1:CAS:528:DC%2BD1MXhs1WhurzO
33. T Gutsmann J Howe U Zähringer P Garidel AB Schromm MHJ Koch Y Fujimoto K Fukase I Moriyon G Martinez de Tejada K Brandenburg 2010 Structural prerequisites for endotoxic activity in the Limulus test as compared to cytokine production in mononuclear cells Innate Immun 16 39 47 10.1177/1753425909106447 1:CAS:528:DC%2BC3cXns1SgtbY%3D
34. T Gutsmann I Razquin-Olazaran I Kowalski Y Kaconis J Howe R Bartels M Hornef T Schürholz M Rössle S Sanchez-Gomez I Moriyon G Martinez de Tejada K Brandenburg 2010 New antiseptic peptides to protect against endotoxin-mediated shock Antimicrob Agents Chemother 54 3817 3824 10.1128/AAC.00534-10 1:CAS:528:DC%2BC3cXht12ktLzP
35. RE Hancock HG Sahl 2006 Antimicrobial and host-defense peptides as new anti-infective therapeutic strategies Nat Biotechnol 24 1551 1557 10.1038/nbt1267 1:CAS:528:DC%2BD28Xht12gtbvM (Pubitemid 44967479)
36. M Hashimoto M Furuyashiki R Kaseya Y Fukada M Akimaru K Aoyama T Okuno T Tamura T Kirikae F Kirikae N Eiraku H Morioka Y Fujimoto K Fukase K Takashige Y Moriya S Kusumoto Y Suda 2007 Evidence of immunostimulating lipoprotein existing in the natural lipoteichoic acid fraction Infect Immun 75 1926 1932 10.1128/IAI.02083-05 1:CAS:528:DC%2BD2sXkt1OhtrY%3D (Pubitemid 46559462)
37. L Haversen N Kondori L Baltzer LA Hanson GT Dolphin K Duner I Mattsby-Baltzer 2010 Structure-microbicidal activity relationship of synthetic fragments derived from the antibacterial alpha-helix of human lactoferrin Antimicrob Agents Chemother 54 418 425 10.1128/AAC.00908-09 1:STN:280: DC%2BD1MfjtlyntQ%3D%3D
38. M Hirata J Zhong SC Wright JW Larrick 1995 Structure and functions of endotoxin-binding peptides derived from CAP18 Prog Clin Biol Res 392 317 326 1:CAS:528:DyaK28XmsFOlsbw%3D
39. A Hoess S Watson GR Siber R Liddington 1993 Crystal structure of an endotoxin-neutralizing protein from the horseshoe crab, Limulus anti-LPS factor, at 1.5 A resolution EMBO J 12 3351 3356 1:CAS:528:DyaK3sXmt1ajurc%3D (Pubitemid 23256421)
40. MW Hornef MJ Wick M Rhen S Normark 2002 Bacterial strategies for overcoming host innate and adaptive immune responses Nat Immunol 3 1033 1040 10.1038/ni1102-1033 1:CAS:528:DC%2BD38Xot1Chsr0%3D (Pubitemid 35363654)
41. J Howe J Andrä R Conde M Iriarte P Garidel MHJ Koch T Gutsmann I Moriyon K Brandenburg 2007 Thermodynamic analysis of the lipopolysaccharide- dependent resistance of gram-negative bacteria against polymyxin B Biophys J 92 2796 2805 10.1529/biophysj.106.095711 1:CAS:528:DC%2BD2sXkt1Cgu7Y%3D (Pubitemid 46557854)
42. B Japelj P Pristovsek A Majerle R Jerala 2005 Structural origin of endotoxin neutralization and antimicrobial activity of a lactoferrin-based peptide J Biol Chem 280 16955 16961 10.1074/jbc.M500266200 1:CAS:528: DC%2BD2MXjsFOgtrw%3D (Pubitemid 41389156)
43. I Kowalski Y Kaconis J Andrä I Razquin-Olazaran T Gutsmann G Martinez de Tejada K Brandenburg 2010 Physicochemical and biological characterization of anti-endotoxin peptides and their Influence on lipid properties Protein Pept Lett 17 1328 1333 1:CAS:528:DC%2BC3cXhsVSrsrzN
44. JW Larrick JG Morgan I Palings M Hirata MH Yen 1991 Complementary DNA sequence of rabbit CAP18-a unique lipopolysaccharide binding protein Biochem Biophys Res Commun 179 170 175 10.1016/0006-291X(91)91350-L 1:CAS:528: DyaK38XltVGnsLc%3D
45. JY Lefrant L Muller A Raillard B Jung L Beaudroit L Favier B Masson G Dingemans F Thevenot D Selcer O Jonquet X Capdevila P Fabbro-Peray S Jaber 2010 Reduction of the severe sepsis or septic shock associated mortality by reinforcement of the recommendations bundle: a multicenter study Ann Fr Anesth Rèanim 29 621 628
46. RI Lehrer T Ganz 2002 Defensins of vertebrate animals Curr Opin Immunol 14 96 102 10.1016/S0952-7915(01)00303-X 1:CAS:528:DC%2BD38XktFKjsw%3D%3D (Pubitemid 34085112)
47. M Leippe 1995 Ancient weapons: NK-lysin is a mammalian homolog to pore-forming peptides of a protozoan parasite Cell 83 17 18 10.1016/0092- 8674(95)90229-5 1:CAS:528:DyaK2MXosF2kurc%3D
48. J Levin 1987 The Limulus amebocyte lysate test: perspectives and problems Prog Clin Biol Res 231 1 23 1:STN:280:DyaL2s3jt1SltQ%3D%3D
49. E Liepinsh M Andersson JM Ruysschaert G Otting 1997 Saposin fold revealed by the NMR structure of NK-lysin Nat Struct Biol 4 793 795 10.1038/nsb1297-975 1:CAS:528:DyaK2sXms1Smsb8%3D (Pubitemid 127742486)
50. J Malm O Sorensen T Persson M Frohm-Nilsson B Johansson A Bjartell H Lilja M Stahle-Backdahl N Borregaard A Egesten 2000 The human cationic antimicrobial protein (hCAP-18) is expressed in the epithelium of human epididymis, is present in seminal plasma at high concentrations, and is attached to spermatozoa Infect Immun 68 4297 4302 10.1128/IAI.68.7.4297-4302.2000 1:CAS:528:DC%2BD3cXktlynur4%3D (Pubitemid 30434586)
51. A Michalopoulos ME Falagas 2008 Colistin and polymyxin B in critical care Crit Care Clin 24 377 391 10.1016/j.ccc.2007.12.003 1:CAS:528: DC%2BD1cXmtFSnsrg%3D (Pubitemid 351400615)
52. DC Morrison 1998 Antibiotic-mediated release of endotoxin and the pathogenesis of Gram-negative sepsis Prog Clin Biol Res 397 199 207 1:CAS:528:DyaK1cXktFais7o%3D
53. D Motzkus S Schulz-Maronde A Heitland A Schulz WG Forssmann M Jubner E Maronde 2006 The novel beta-defensin DEFB123 prevents lipopolysaccharide- mediated effects in vitro and in vivo FASEB J 20 1701 1702 10.1096/fj.05-4970fje 1:CAS:528:DC%2BD28Xot1Git7g%3D (Pubitemid 44943777)
54. 106-138-immunoglobulin G in whole blood Infect Immun 65 2160 2167 1:CAS:528:DyaK2sXjsFWhtbc%3D (Pubitemid 27237292)
55. SM Opal J Cohen 1999 Clinical Gram-positive sepsis: does it fundamentally differ from Gram-negative bacterial sepsis? Crit Care Med 27 1608 1616 10.1097/00003246-199908000-00039 1:STN:280:DyaK1Mzpslektg%3D%3D (Pubitemid 29406956)
56. CY Pan TT Chao JC Chen JY Chen WC Liu CH Lin CM Kuo 2007 Shrimp (Penaeus monodon) anti-lipopolysaccharide factor reduces the lethality of Pseudomonas aeruginosa sepsis in mice Int Immunopharmacol 7 687 700 10.1016/j.intimp.2007. 01.006 1:CAS:528:DC%2BD2sXjsVSqu7Y%3D (Pubitemid 46464042)
57. Pena SV, Hanson DA, Carr BA, Goralski TJ, Krensky AM (1997) Processing, subcellular localization, and function of 519 (Granulysin), a human late T cell sctivation molecule with homology to small, lytic, granule proteins. J Immunol 158: 2680-2688 (Pubitemid 127470525)
58. A Pini C Falciani E Mantengoli S Bindi J Brunetti S Iozzi RG Maria L Bracci 2009 A novel tetrabranched antimicrobial peptide that neutralizes bacterial lipopolysaccharide and prevents septic shock in vivo FASEB J 24 1015 1022 10.1096/fj.09-145474
59. K Reinhart W Karzai 2001 Anti-tumor necrosis factor therapy in sepsis: update on clinical trials and lessons learned Crit Care Med 7 S121 S125 10.1097/00003246-200107001-00037
60. JD Ren JS Gu HF Gao PY Xia GX Xiao 2008 A synthetic cyclic peptide derived from Limulus anti-lipopolysaccharide factor neutralizes endotoxin in vitro and in vivo Int Immunopharmacol 8 775 781 10.1016/j.intimp.2008.01.015 1:CAS:528:DC%2BD1cXls1Sgsrg%3D
61. C Ried C Wahl T Miethke G Wellnhofer C Landgraf J Schneider-Mergener A Hoess 1996 High affinity endotoxin-binding and neutralizing peptides based on the crystal structure of recombinant Limulus anti-lipopolysaccharide factor J Biol Chem 271 28120 28127 10.1074/jbc.271.45.28120 1:CAS:528:DyaK28XmvVWlur0%3D (Pubitemid 26374620)
62. MG Scott ACE Vreugdenhil WA Buurman REW Hancock M Gold 2000 Cationic antimicrobial peptides block the binding of lipopolysaccharide (LPS) to LPS binding protein J Immunol 164 549 553 1:CAS:528:DC%2BD3cXlt1Chtg%3D%3D (Pubitemid 30043670)
63. O Sorensen JB Cowland J Askaa N Borregaard 1997 An ELISA for hCAP-18, the cathelicidin present in human neutrophils and plasma J Immunol Meth 206 53 59 10.1016/S0022-1759(97)00084-7 1:CAS:528:DyaK2sXltVGju7c%3D (Pubitemid 27395865)
64. M Tidswell W Tillis SP LaRosa M Lynn AE Wittek R Kao J Wheller J Gogate SM Opal Eritoran Sepsis Study Group 2010 Phase 2 trial od eritoran tetrasodium (E5564), a Toll-like receptor 4 antagonist, in patients with severe sepsis Crit Care Med 38 72 83 10.1097/CCM.0b013e3181b07b78 1:CAS:528:DC%2BD1MXhsFyhsL7F
65. SM Travis NN Anderson WR Forsyth C Espiritu BD Conway EP Greenberg PB McCray RI Lehrer MJ Welsh BF Tack 2000 Bactericidal activity of mammalian cathelicidin-derived peptides Infect Immun 68 2748 2755 10.1128/IAI.68.5.2748- 2755.2000 1:CAS:528:DC%2BD3cXivVamtLg%3D (Pubitemid 30253851)
66. Q Wang Y Wang P Xu Z Liu 2006 NK-lysin of channel catfish: gene triplication, sequence variation, and expression analysis Mol Immunol 43 1676 1686 10.1016/j.molimm.2005.09.023 1:CAS:528:DC%2BD28XhvF2gtb0%3D
67. M Wieczorek H Jenssen J Kindrachuk WR Scott M Elliott K Hilpert JT Cheng RE Hancock SK Straus 2010 Structural studies of a peptide with immune modulating and direct antimicrobial activity Chem Biol 17 970 980 10.1016/j.chembiol.2010. 07.007 1:CAS:528:DC%2BC3cXhtFyit7fF
68. SH Yang R Tamai S Akashi O Takeuchi S Akira S Sugawara H Takada 2001 Synergistic effect of muramyldipeptide with lipopolysaccharide or lipoteichoic acid to induce inflammatory cytokines in human monocytic cells in culture Infect Immun 69 2045 2053 10.1128/IAI.69.4.2045-2053.2001 1:CAS:528: DC%2BD3MXisVSmtbs%3D (Pubitemid 32239668)
69. M Zanetti R Gennaro D Romeo 1995 Cathelicidins: a novel protein family with a common proregion and a variable C-terminal antimicrobial domain FEBS Lett 374 1 5 10.1016/0014-5793(95)01050-O 1:CAS:528:DyaK2MXovVynsr0%3D